by | Dec 30, 2022 | Uncategorized
The COVID-19 pandemic may have had an effect on treatment approaches for patients with multiple myeloma, according to study results presented at ASH Annual Meeting and Exposition.Robert M. Rifkin, MD, FACP — medical oncologist and hematologist at Rocky Mountain Cancer...
by | Dec 28, 2022 | Uncategorized
Source: Cure Today articles Initially, we used my husband’s diagnosis to show our support as we navigated this journey and joined a new “club” we really didn’t want to be a part of. Read More
by | Dec 28, 2022 | Uncategorized
NEW ORLEANS — In this video perspective, Nikhil C. Munshi, MD, discusses presentations from the ASH Annual Meeting and Exposition that focus on advances in bispecific antibody treatments for patients with multiple myeloma.New data on teclistamab, elranatamab,...
by | Dec 27, 2022 | Uncategorized
Source: Cure Today articles Cynthia Chmielewski is a multiple myeloma hero for many around the world. Read More
by | Dec 27, 2022 | Uncategorized
A county’s poverty rate appeared significantly associated with the likelihood it would be home to at least one registered multiple myeloma clinical trial site, according to study results.Researchers used ClinicalTrials.gov to assess the availability of multiple...
by | Dec 26, 2022 | Uncategorized
Source: Cure Today articles He dreams that this ever-growing body of knowledge will progressively improve the ability to understand and treat cancer; multiple myeloma has been at the center of this dream. Read More
